Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL). | MicrobiomeTrials
Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2028-09-01
Enrollment target: 82 participants
Other microbiome trials you might be interested in